These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10449196)

  • 1. Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin.
    Mancini F; Toro CM; Mabilia M; Giannangeli M; Pinza M; Milanese C
    Biochem Pharmacol; 1999 Sep; 58(5):851-9. PubMed ID: 10449196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suramin inhibits death receptor-induced apoptosis in vitro and fulminant apoptotic liver damage in mice.
    Eichhorst ST; Krueger A; Müerköster S; Fas SC; Golks A; Gruetzner U; Schubert L; Opelz C; Bilzer M; Gerbes AL; Krammer PH
    Nat Med; 2004 Jun; 10(6):602-9. PubMed ID: 15146177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.
    Carter PH; Scherle PA; Muckelbauer JK; Voss ME; Liu RQ; Thompson LA; Tebben AJ; Solomon KA; Lo YC; Li Z; Strzemienski P; Yang G; Falahatpisheh N; Xu M; Wu Z; Farrow NA; Ramnarayan K; Wang J; Rideout D; Yalamoori V; Domaille P; Underwood DJ; Trzaskos JM; Friedman SM; Newton RC; Decicco CP
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):11879-84. PubMed ID: 11592999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of suramin-induced deoligomerization of tumor necrosis factor alpha.
    Alzani R; Cozzi E; Corti A; Temponi M; Trizio D; Gigli M; Rizzo V
    Biochemistry; 1995 May; 34(19):6344-50. PubMed ID: 7756262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p55 tumor necrosis factor receptor (CD120a) induces endothelin-1 synthesis in endothelial and epithelial cells.
    Lees DM; Pallikaros Z; Corder R
    Eur J Pharmacol; 2000 Feb; 390(1-2):89-94. PubMed ID: 10708710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells.
    Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC
    AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site.
    Morgan HP; McNae IW; Nowicki MW; Zhong W; Michels PA; Auld DS; Fothergill-Gilmore LA; Walkinshaw MD
    J Biol Chem; 2011 Sep; 286(36):31232-40. PubMed ID: 21733839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I.
    Hildt E; Oess S
    J Exp Med; 1999 Jun; 189(11):1707-14. PubMed ID: 10359574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suramin induces deoligomerization of human tumor necrosis factor alpha.
    Alzani R; Corti A; Grazioli L; Cozzi E; Ghezzi P; Marcucci F
    J Biol Chem; 1993 Jun; 268(17):12526-9. PubMed ID: 8509393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.
    Amrani Y; Panettieri RA; Frossard N; Bronner C
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):55-63. PubMed ID: 8679222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
    Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
    Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor.
    Takasaki W; Kajino Y; Kajino K; Murali R; Greene MI
    Nat Biotechnol; 1997 Nov; 15(12):1266-70. PubMed ID: 9359109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of receptor/G protein coupling by suramin analogues.
    Beindl W; Mitterauer T; Hohenegger M; Ijzerman AP; Nanoff C; Freissmuth M
    Mol Pharmacol; 1996 Aug; 50(2):415-23. PubMed ID: 8700151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel tumor necrosis factor-alpha mutant with significantly enhanced cytotoxicity and receptor binding affinity.
    Shin NK; Lee I; Chang SG; Shin HC
    Biochem Mol Biol Int; 1998 May; 44(6):1075-82. PubMed ID: 9623760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective.
    Barbara JA; Van ostade X; Lopez A
    Immunol Cell Biol; 1996 Oct; 74(5):434-43. PubMed ID: 8912006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suramin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of NF-kappaB activity.
    Goto T; Takeuchi S; Miura K; Ohshima S; Mikami K; Yoneyama K; Sato M; Shibuya T; Watanabe D; Kataoka E; Segawa D; Endo A; Sato W; Yoshino R; Watanabe S
    Cytokine; 2006 Jan; 33(1):28-35. PubMed ID: 16413198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling.
    Chan FK; Chun HJ; Zheng L; Siegel RM; Bui KL; Lenardo MJ
    Science; 2000 Jun; 288(5475):2351-4. PubMed ID: 10875917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early events in TNFa-p55 receptor interations--experiments with TNF dimers.
    Menart V; Gaberc-Porekar V; Jevsevar S; Pernus M; Meager A; Stalc A
    Pflugers Arch; 2000; 439(3 Suppl):R113-5. PubMed ID: 10653161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor alpha.
    Grazioli L; Alzani R; Ciomei M; Mariani M; Restivo A; Cozzi E; Marcucci F
    Int J Immunopharmacol; 1992 May; 14(4):637-42. PubMed ID: 1325955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.